Literature DB >> 14963042

Pleckstrin homology and phosphotyrosine-binding domain-dependent membrane association and tyrosine phosphorylation of Dok-4, an inhibitory adapter molecule expressed in epithelial cells.

Arda Bedirian1, Cindy Baldwin, Jun-ichi Abe, Tomoko Takano, Serge Lemay.   

Abstract

Dok-like adapter molecules represent an expanding family of pleckstrin homology (PH) and phosphotyrosine-binding (PTB) domain-containing tyrosine kinase substrates with negative regulatory functions in hematopoietic cell signaling. In a search for nonhematopoietic counterparts to Dok molecules, we identified and characterized Dok-4, a recently cloned member of the family. dok-4 mRNA was strongly expressed in nonhematopoietic organs, particularly the intestine, kidney, and lung, whereas both mRNA and protein were expressed at high levels in cells of epithelial origin. In Caco-2 human colon cancer cells, endogenous Dok-4 underwent tyrosine phosphorylation in response to pervanadate stimulation. In transfected COS cells, Dok-4 was a substrate for the cytosolic tyrosine kinases Src and Fyn as well as for Jak2. Dok-4 could also be phosphorylated by the receptor tyrosine kinase Ret but not by platelet-derived growth factor receptor-beta or IGF-IR. In both mammalian cells and yeast, Dok-4 was constitutively localized at the membrane in a manner that required both its PH and PTB domains. The PH and PTB domains of Dok-4 were also required for tyrosine phosphorylation of Dok-4 by Fyn and Ret. Finally, wild type Dok-4 strongly inhibited activation of Elk-1 induced by either Ret or Fyn. The attenuation of this inhibitory effect by deletion of the PH domain and its restoration by the addition of a myristoylation signal suggested an important role for constitutive membrane localization of Dok-4. In summary, Dok-4 is a constitutively membrane-localized adapter molecule that may function as an inhibitor of tyrosine kinase signaling in epithelial cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14963042     DOI: 10.1074/jbc.M310689200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Detection of homo- or hetero-association of Doks by fluorescence resonance energy transfer in living cells.

Authors:  Feng Zhang; Guo Fu; Chen Wang; Li Cao; Hua-Yan Yang; Gui-Ying Wang; Yi-Zhang Chen; Cheng He
Journal:  Mol Imaging Biol       Date:  2008-11-25       Impact factor: 3.488

2.  Dok-2 adaptor protein regulates the shear-dependent adhesive function of platelet integrin αIIbβ3 in mice.

Authors:  Sascha C Hughan; Christopher M Spring; Simone M Schoenwaelder; Sharelle Sturgeon; Imala Alwis; Yuping Yuan; James D McFadyen; Erik Westein; Duncan Goddard; Akiko Ono; Yuji Yamanashi; Warwick S Nesbitt; Shaun P Jackson
Journal:  J Biol Chem       Date:  2014-01-02       Impact factor: 5.157

3.  Dok-4 is a novel negative regulator of T cell activation.

Authors:  Audrey Gérard; Marguerite Ghiotto; Camille Fos; Geoffrey Guittard; Daniel Compagno; Anne Galy; Serge Lemay; Daniel Olive; Jacques A Nunès
Journal:  J Immunol       Date:  2009-06-15       Impact factor: 5.422

4.  Downstream of tyrosine kinase/docking protein 6, as a novel substrate of tropomyosin-related kinase C receptor, is involved in neurotrophin 3-mediated neurite outgrowth in mouse cortex neurons.

Authors:  Wei qi Li; Lei Shi; Yuan gang You; Yan hua Gong; Bin Yin; Jian gang Yuan; Xiao zhong Peng
Journal:  BMC Biol       Date:  2010-06-18       Impact factor: 7.431

5.  Expression of microRNA and their gene targets are dysregulated in preinvasive breast cancer.

Authors:  Bethany N Hannafon; Paola Sebastiani; Antonio de las Morenas; Jining Lu; Carol L Rosenberg
Journal:  Breast Cancer Res       Date:  2011-03-04       Impact factor: 6.466

6.  The downstream of tyrosine kinase 7 is reduced in lung cancer and is associated with poor survival of patients with lung cancer.

Authors:  Gang Chen; Hefen Yu; Lucy Satherley; Catherine Zabkiewicz; Jeyna Resaul; Huishan Zhao; Hu Mu; Xiuyi Zhi; Junqi He; Lin Ye; Wen G Jiang
Journal:  Oncol Rep       Date:  2017-03-31       Impact factor: 3.906

Review 7.  Regulation of Src Family Kinases during Colorectal Cancer Development and Its Clinical Implications.

Authors:  Wook Jin
Journal:  Cancers (Basel)       Date:  2020-05-23       Impact factor: 6.639

8.  A Novel Four-Gene Score to Predict Pathologically Complete (R0) Resection and Survival in Pancreatic Cancer.

Authors:  Masanori Oshi; Yoshihisa Tokumaru; Ankit Patel; Li Yan; Ryusei Matsuyama; Itaru Endo; Matthew H G Katz; Kazuaki Takabe
Journal:  Cancers (Basel)       Date:  2020-12-04       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.